ホーム > 市場調査レポート > 医薬品 > 製薬企業関連 > 各国市場における医薬品の市販後ブランドマーケティング動向
カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

各国市場における医薬品の市販後ブランドマーケティング動向

Post-Launch Brand Marketing in Select Affiliate Markets

発行 Cutting Edge Information
出版日 2007年01月 商品コード 47316
ページ情報 英文 87 Slides
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年12月09日を持ちまして終了しました。

原文目次

Abstract

Introduction-Cutting Edge Information published this report to assist individuals and teams who seek guidance in the allocation of post-launch marketing resources for pharmaceutical and biotechnology brands in specific affiliate markets around the world.

The information contained in this report is gathered from brand managers and directors, marketing team members, and vice presidents of marketing at several different companies. These brands' examples - which address a range of competitive pressures, resource support situations, clinical proficiency, and commercial prospects - provide models for teams moving to post-launch with varying levels of resource support.

Uncover real-world brand budgets from the first three years on the market:

Explore marketing budgets for 8 brands throughout their first, second and third years of market availability.

The brands are marketed in the following markets:

  • Asia/Japan (two brands)
  • Australia (one brand)
  • Canada (one brand)
  • Mexico (one brand)
  • Philippines (one brand)
  • South Africa (one brand)
  • Sri Lanka (one brand)
Each easy-to-navigate brand profile walks you through annual spending in three critical areas of product management:
  • Promotional Mix
    • Detail Aids
    • Samples
    • Speaker programs
    • Journal ads
    • Medical publications
    • Medical education
    • Patient education programs
    • DTC ads
  • Decision Support
    • Market research
    • Competitive intelligence
  • Market Access
    • Pricing strategy and analysis
    • Pharmacoeconomics
    • Reimbursement

Companies Included in Report

Brand data were collected from the following pharmaceutical and biotechnology companies:

  • Biogen Idec
  • Ferring Pharmaceuticals
  • GlaxoSmithKline Team 1
  • GlaxoSmithKline Team 2
  • Panpharma
  • Popular Pharmaceuticals
  • Sanfer
  • Sanofi-Aventis

Table of Contents

Executive Summary

  • Introduction
  • Contributing Companies
  • Definitions: Time Segments
  • Definitions: Resource Categories
  • Definitions: Promotional Mix
  • Definitions: Decision Support
  • Definitions: Market Access

Section 1: Asia/Oceania

  • Brand 1: Sri Lanka, Infectious Diseases Product
  • Brand 2: Philippines, Infectious Diseases Product
  • Brand 3: Japan/Pan-Asia, Women' s Health Product
  • Brand 4: Australia, Respiratory Product
  • Brand 5: Japan/Pan-Asia, Cardiovascular Product

Section 2: Americas

  • Brand 6: Mexico, Cardiovascular Product
  • Brand 7: Canada, Central Nervous System Product

Section 3: Africa

  • Brand 8: South Africa, Cardiovascular Product
Back to Top